Papillary thyroid carcinoma was seen in one (5.6%) seronegative patient, and lung small-cell carcinoma was seen in one (5.6%) patient with anti-TIF1ɣ + anti-Mi2α (Table 3). This evidence concerns the gene CHD3 and small cell lung carcinoma.